Tokyo Tape
Sign in
← Sundrug

Quarterly report · Q2

9989.TEDINET S100SAP5
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥371.7bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥690.5bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥339.2bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥20.6bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥18.5bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥21.0bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥38.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥18.8bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥20.6bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥18.5bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥14.1bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥25.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥12.7bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥14.1bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥12.7bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥369.9bnat 2023-09-30Cons.Assets
Total assets¥360.7bnat 2023-03-31Cons.Assets
Total assets¥337.1bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥125.2bnat 2023-09-30Cons.Liabilities
Total liabilities¥124.3bnat 2023-03-31Cons.Liabilities
Net assets / equity¥244.7bnat 2023-09-30Cons.Net assets
Net assets / equity¥236.3bnat 2023-03-31Cons.Net assets
Net assets / equity¥229.1bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥76.8bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥80.9bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥76.8bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥80.9bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥94.5bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥89.3bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥23.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥37.4bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥21.4bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥21.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥28.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥12.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥5.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥17.3bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥4.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥120.22023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥61.182023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥219.832022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥108.812022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥54.942022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥219.822022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥108.812022-04-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio66.1%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio65.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio68.0%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥26.1bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥26.1bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue2023-04-01 → 2023-09-30¥155.0bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue external2023-04-01 → 2023-09-30¥155.0bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥5m
jpcrp040300-q2r_E03226-000Discount Storereportable segmentsegment profit2023-04-01 → 2023-09-30¥7.5bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue2023-04-01 → 2023-09-30¥242.8bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue external2023-04-01 → 2023-09-30¥216.7bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥26.1bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentsegment profit2023-04-01 → 2023-09-30¥13.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥397.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥371.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥26.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥20.6bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥24.7bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥24.7bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue2022-04-01 → 2022-09-30¥143.9bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue external2022-04-01 → 2022-09-30¥143.9bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥5m
jpcrp040300-q2r_E03226-000Discount Storereportable segmentsegment profit2022-04-01 → 2022-09-30¥6.7bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue2022-04-01 → 2022-09-30¥220.0bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue external2022-04-01 → 2022-09-30¥195.3bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥24.7bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentsegment profit2022-04-01 → 2022-09-30¥11.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥363.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥339.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥24.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥18.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 479
ItemContextValueUnit
Allowance for doubtful accounts caPrior1YearInstant-5000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-5000000JPY
Current assetsPrior1YearInstant205907000000JPY
Current assetsCurrentQuarterInstant206351000000JPY
Buildings and structures netPrior1YearInstant71341000000JPY
Buildings and structures netCurrentQuarterInstant74794000000JPY
Other net ppePrior1YearInstant28906000000JPY
Other net ppeCurrentQuarterInstant33907000000JPY
Property plant and equipmentPrior1YearInstant100248000000JPY
Property plant and equipmentCurrentQuarterInstant108701000000JPY
GoodwillPrior1YearInstant1671000000JPY
GoodwillCurrentQuarterInstant1613000000JPY
Other iaPrior1YearInstant7433000000JPY
Other iaCurrentQuarterInstant7702000000JPY
Intangible assetsPrior1YearInstant9104000000JPY
Intangible assetsCurrentQuarterInstant9316000000JPY
Lease and guarantee depositsPrior1YearInstant26825000000JPY
Lease and guarantee depositsCurrentQuarterInstant26928000000JPY
Other ioaPrior1YearInstant18662000000JPY
Other ioaCurrentQuarterInstant18670000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-75000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-84000000JPY
Investments and other assetsPrior1YearInstant45411000000JPY
Investments and other assetsCurrentQuarterInstant45515000000JPY
Noncurrent assetsPrior1YearInstant154764000000JPY
Noncurrent assetsCurrentQuarterInstant163533000000JPY
AssetsPrior1YearInstant360672000000JPY
AssetsCurrentQuarterInstant369884000000JPY
Accounts payable tradePrior1YearInstant74006000000JPY
Accounts payable tradeCurrentQuarterInstant75231000000JPY
Income taxes payablePrior1YearInstant8249000000JPY
Income taxes payableCurrentQuarterInstant7337000000JPY
Provision for directors bonusesPrior1YearInstant120000000JPY
Provision for directors bonusesCurrentQuarterInstant36000000JPY
Other clPrior1YearInstant30872000000JPY
Other clCurrentQuarterInstant31379000000JPY
Current liabilitiesPrior1YearInstant113249000000JPY
Current liabilitiesCurrentQuarterInstant113985000000JPY
Provision for directors retirement benefitsPrior1YearInstant303000000JPY
Provision for directors retirement benefitsCurrentQuarterInstant309000000JPY
Net defined benefit liabilityPrior1YearInstant1993000000JPY
Net defined benefit liabilityCurrentQuarterInstant2071000000JPY
Asset retirement obligations nclPrior1YearInstant6156000000JPY
Asset retirement obligations nclCurrentQuarterInstant6281000000JPY
Other nclPrior1YearInstant2641000000JPY
Other nclCurrentQuarterInstant2569000000JPY
Noncurrent liabilitiesPrior1YearInstant11095000000JPY
Noncurrent liabilitiesCurrentQuarterInstant11231000000JPY
LiabilitiesPrior1YearInstant124344000000JPY
LiabilitiesCurrentQuarterInstant125217000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass